CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk
Overview
Affiliations
Breastfeeding provides the ideal nutrition for infants. Human milk contains a plethora of functional ingredients which foster the development of the immune system. The human milk microbiota predominantly contributes to this protective effect. This is mediated by various mechanisms, such as an antimicrobial effect, pathogen exclusion and barrier integrity, beneficial effects on the gastrointestinal microbiota, vitamin synthesis, immunity enhancement, secreted probiotic factors, and postbiotic mechanisms. Therefore, human milk is a good source for isolating probiotics for infants who cannot be exclusively breastfed. One such probiotic which was isolated from human milk is CECT5716. In this review, we give an overview of available interventional studies using CECT5716 and summarise preclinical trials in several animal models of different pathologies, which have given first insights into its mechanisms of action. We present several randomised clinical studies, which have been conducted to investigate the clinical efficacy of the CECT5716 strain in supporting the host's health.
Wang F, Li X, Wang Q, Jin Q, Xu S, Tang L Probiotics Antimicrob Proteins. 2024; .
PMID: 39621210 DOI: 10.1007/s12602-024-10408-y.
Senthil Kumar S, Sheik Mohideen S Sci Rep. 2024; 14(1):21182.
PMID: 39261567 PMC: 11390943. DOI: 10.1038/s41598-024-72200-w.
interacts with multiple gut bacteria.
Xu C, Jiang H, Feng L, Jiang M, Wang Y, Liu S Front Microbiol. 2024; 15:1301073.
PMID: 38440147 PMC: 10910051. DOI: 10.3389/fmicb.2024.1301073.
Short-chain fatty acids in breast milk and their relationship with the infant gut microbiota.
Xi M, Yan Y, Duan S, Li T, Szeto I, Zhao A Front Microbiol. 2024; 15:1356462.
PMID: 38440144 PMC: 10909814. DOI: 10.3389/fmicb.2024.1356462.